Diagnos Inc (ADK) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.539x

Based on the latest financial reports, Diagnos Inc (ADK) has a cash flow conversion efficiency ratio of 0.539x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-828.10K ≈ $-599.04K USD) by net assets (CA$-1.54 Million ≈ $-1.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Diagnos Inc (ADK) total market value for the company's overall valuation and market capitalisation.

Diagnos Inc - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Diagnos Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diagnos Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diagnos Inc ranked by their cash flow conversion efficiency. Explore ADK operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Eastern Commercial Leasing Public Company Limited
BK:ECL
0.103x
TPC CONSOLIDATED LTD.
F:T7P
N/A
Energía Innovación y Desarrollo Fotovoltaico S.A.
MC:EIDF
-21.569x
HCT Co. Ltd
KQ:072990
0.186x
HI SPAC 3
KQ:217500
-0.025x
ENERGIA IN.Y DES. EO 025
F:F63
N/A
Lotus KFM Bhd
KLSE:8303
0.005x
Barinthus Biotherapeutics plc
NASDAQ:BRNS
-0.127x

Annual Cash Flow Conversion Efficiency for Diagnos Inc (2002–2025)

The table below shows the annual cash flow conversion efficiency of Diagnos Inc from 2002 to 2025. View Diagnos Inc (ADK) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$233.11K
≈ $168.63K
CA$-3.64 Million
≈ $-2.63 Million
-15.604x -2076.03%
2024-03-31 CA$-3.05 Million
≈ $-2.21 Million
CA$-2.41 Million
≈ $-1.74 Million
0.790x -18.33%
2023-03-31 CA$-1.95 Million
≈ $-1.41 Million
CA$-1.88 Million
≈ $-1.36 Million
0.967x -94.61%
2022-03-31 CA$-113.51K
≈ $-82.11K
CA$-2.04 Million
≈ $-1.47 Million
17.954x +1598.12%
2021-03-31 CA$1.13 Million
≈ $818.98K
CA$-1.36 Million
≈ $-981.49K
-1.198x +17.44%
2020-03-31 CA$1.82 Million
≈ $1.32 Million
CA$-2.64 Million
≈ $-1.91 Million
-1.452x -418.05%
2019-03-31 CA$-5.08 Million
≈ $-3.68 Million
CA$-2.32 Million
≈ $-1.68 Million
0.456x -26.02%
2018-03-31 CA$-3.64 Million
≈ $-2.63 Million
CA$-2.24 Million
≈ $-1.62 Million
0.617x +92.48%
2017-03-31 CA$-5.58 Million
≈ $-4.03 Million
CA$-1.79 Million
≈ $-1.29 Million
0.321x -54.80%
2016-03-31 CA$-3.15 Million
≈ $-2.28 Million
CA$-2.23 Million
≈ $-1.62 Million
0.709x -94.44%
2015-03-31 CA$-224.85K
≈ $-162.65K
CA$-2.87 Million
≈ $-2.07 Million
12.748x +464.40%
2014-03-31 CA$346.95K
≈ $250.98K
CA$-1.21 Million
≈ $-878.01K
-3.498x -204.12%
2013-03-31 CA$1.75 Million
≈ $1.26 Million
CA$-2.01 Million
≈ $-1.45 Million
-1.150x -41.39%
2012-03-31 CA$2.34 Million
≈ $1.70 Million
CA$-1.91 Million
≈ $-1.38 Million
-0.814x +31.73%
2011-03-31 CA$1.18 Million
≈ $855.17K
CA$-1.41 Million
≈ $-1.02 Million
-1.192x -56.73%
2010-03-31 CA$1.98 Million
≈ $1.43 Million
CA$-1.51 Million
≈ $-1.09 Million
-0.760x -4.87%
2009-03-31 CA$2.41 Million
≈ $1.74 Million
CA$-1.75 Million
≈ $-1.26 Million
-0.725x -557420.15%
2008-03-31 CA$4.21 Million
≈ $3.04 Million
CA$-547.00
≈ $-395.69
0.000x +99.98%
2007-03-31 CA$1.42 Million
≈ $1.03 Million
CA$-876.30K
≈ $-633.90K
-0.616x +60.42%
2006-03-31 CA$793.68K
≈ $574.14K
CA$-1.24 Million
≈ $-894.18K
-1.557x +86.16%
2005-03-31 CA$161.61K
≈ $116.91K
CA$-1.82 Million
≈ $-1.32 Million
-11.252x -1503.98%
2004-03-31 CA$-128.75K
≈ $-93.14K
CA$-103.19K
≈ $-74.64K
0.801x -73.66%
2003-03-31 CA$-264.64K
≈ $-191.44K
CA$-805.06K
≈ $-582.37K
3.042x -56.40%
2002-03-31 CA$-325.75K
≈ $-235.64K
CA$-2.27 Million
≈ $-1.64 Million
6.978x --

About Diagnos Inc

V:ADK Canada Health Information Services
Market Cap
$33.90 Million
CA$46.86 Million CAD
Market Cap Rank
#23975 Global
#893 in Canada
Share Price
CA$0.46
Change (1 day)
-6.12%
52-Week Range
CA$0.19 - CA$0.51
All Time High
CA$1.95
About

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and patho… Read more